Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.31B |
| 2 |
Apple
AAPL
|
+$1.25B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$934M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$451M |
| 5 |
Tesla
TSLA
|
+$436M |
Top Sells
| 1 |
Alibaba
BABA
|
+$1.27B |
| 2 |
Canadian Natural Resources
CNQ
|
+$876M |
| 3 |
Enbridge
ENB
|
+$540M |
| 4 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$469M |
| 5 |
Suncor Energy
SU
|
+$461M |
Sector Composition
| 1 | Technology | 19.35% |
| 2 | Healthcare | 10.12% |
| 3 | Financials | 9.64% |
| 4 | Consumer Discretionary | 8.55% |
| 5 | Industrials | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Ternium
TX
$6.8B
| $13.5M | ﹤0.01% |
327,955
+247,871
| +310% | +$10.2M |
|
1777
Ennis
EBF
$463M
| $13.5M | ﹤0.01% |
640,815
+57,485
| +10% | +$1.21M |
|
1778
Fortis
FTS
$24.9B
| $13.5M | ﹤0.01% |
317,305
+2,818
| +0.9% | +$120K |
|
1779
Appian
APPN
$2.28B
| $13.5M | ﹤0.01% |
303,725
+71,244
| +31% | +$3.16M |
|
1780
CommScope
COMM
$3.61B
| $13.4M | ﹤0.01% |
2,106,536
+380,034
| +22% | +$2.42M |
|
1781
Essent Group
ESNT
$6.29B
| $13.4M | ﹤0.01% |
334,038
-81,398
| -20% | -$3.26M |
|
1782
Empire State Realty Trust
ESRT
$1.34B
| $13.4M | ﹤0.01% |
2,061,104
-818,587
| -28% | -$5.31M |
|
1783
SPDR S&P Aerospace & Defense ETF
XAR
$4.05B
| $13.3M | ﹤0.01% |
113,783
-796
| -0.7% | -$93.1K |
|
1784
A-Mark Precious Metals
AMRK
$664M
| $13.3M | ﹤0.01% |
383,861
+96,982
| +34% | +$3.36M |
|
1785
Kura Oncology
KURA
$711M
| $13.3M | ﹤0.01% |
1,086,800
-60,691
| -5% | -$742K |
|
1786
Sturm, Ruger & Co
RGR
$600M
| $13.3M | ﹤0.01% |
231,367
+29,132
| +14% | +$1.67M |
|
1787
Adaptive Biotechnologies
ADPT
$1.92B
| $13.2M | ﹤0.01% |
1,499,737
+209,162
| +16% | +$1.85M |
|
1788
Denali Therapeutics
DNLI
$2.07B
| $13.2M | ﹤0.01% |
572,843
-198,609
| -26% | -$4.58M |
|
1789
Teradata
TDC
$2B
| $13.2M | ﹤0.01% |
327,102
-298,925
| -48% | -$12M |
|
1790
Krispy Kreme
DNUT
$541M
| $13.1M | ﹤0.01% |
844,716
-165,738
| -16% | -$2.58M |
|
1791
Synovus
SNV
$7.18B
| $13.1M | ﹤0.01% |
425,759
-1,553,493
| -78% | -$47.9M |
|
1792
Roivant Sciences
ROIV
$9.61B
| $13.1M | ﹤0.01% |
1,775,191
+1,253,849
| +241% | +$9.25M |
|
1793
Cracker Barrel
CBRL
$1.14B
| $13.1M | ﹤0.01% |
114,965
-9,463
| -8% | -$1.08M |
|
1794
Brink's
BCO
$4.83B
| $13M | ﹤0.01% |
195,250
-55,427
| -22% | -$3.7M |
|
1795
Upstart Holdings
UPST
$6.07B
| $13M | ﹤0.01% |
818,951
-16,480
| -2% | -$262K |
|
1796
National Vision
EYE
$1.82B
| $13M | ﹤0.01% |
690,707
-39,840
| -5% | -$751K |
|
1797
SPDR S&P Pharmaceuticals ETF
XPH
$184M
| $13M | ﹤0.01% |
317,137
+50,437
| +19% | +$2.07M |
|
1798
ADT
ADT
$7.24B
| $13M | ﹤0.01% |
1,796,457
-107,036
| -6% | -$774K |
|
|
RETA
1799
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $13M | ﹤0.01% |
142,799
-130,419
| -48% | -$11.9M |
|
1800
Thor Industries
THO
$5.55B
| $13M | ﹤0.01% |
162,922
-107,606
| -40% | -$8.57M |
|